Garden Health - What Was It Like Growing Up?

5min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

Gardentil is a biotech company that focuses on clinical genomics. It's looking at blood tests and looking at the tumor associated biomarkers in blood samples for different kind of application in oncology. In 2011, 2012, even early part of 2013, it looked mission impossible from perspective of many key opinion leaders in the field to really marry next generation sequencing technologies with finding these biomarker in blood since those biomarkers are very rare. The first effort did not work at the garden.

This week, we’re super excited to have AmirAli Talasaz, co-CEO and co-founder of Guardant Health, a leading precision oncology company focused on helping conquer cancer globally.

Founded in 2011, Guardant Health is focused on helping conquer cancer through the use of its proprietary blood-based tests, vast data sets and advanced analytics. Guardant’s solutions include treatment selection, recurrence detection and early detection of cancer. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum.

Through multiple rounds of private financing, Guardant Health raised over $500 million from investors including Sequoia, Khosla, Lightspeed, OrbiMed, and Softbank, and Pear! and Guardant completed a successful IPO in October 2018.